Navigation Links
Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
Date:4/26/2012

15, volunteers were immediately switched to the alternate formulation for Period Two (days 15-28), without washout.  Pharmacokinetic profiles were determined through blood samples taken at steady-state (days 14 and 28) and at switch (day 15).  Steady-state was considered maintained if slope estimates for minimum concentrations (Cmin) were not significantly different from zero.  Tolerability of USL255 and IR topiramate were evaluated through adverse events monitoring, vital sign measurements, and clinical laboratory evaluations.  The results for both formulations were similar at steady-state and around the switch in formulation.  Additionally, no significant differences in slope estimates were identified during conversion, suggesting that switching formulations did not affect maintenance of steady-state plasma concentrations.

The final poster assessed dose-proportionality, linearity and tolerability of USL255.  In this Phase I, single-dose, open-label, 5-way crossover study, 30 healthy subjects were randomized into one of five treatment sequences with six subjects per sequence.  Subjects were given each dose of USL255 (25, 50, 100, 200 and 400 mg) in varying order depending on their assigned treatment sequence.  Following each treatment, subjects entered a three week washout period with blood samples being collected throughout the first 14 days.  The investigators concluded that USL255's topiramate exposure was linear and dose-proportional from 25 mg up to 400 mg.  Subsequent analyses compared dose-normalized Cmax values of USL255 400 mg to 200 mg, and 200 mg to 100 mg.  All 90% confidence intervals were between 0.80 – 1.25 which indicates that Cmax changed dose-proportionally within double-dose increases between 100 mg and 400 mg.  As expected, the number of subjects who experienced a treatment-emergent adverse event generally increased with ascending doses, and all were mild to moderate in sev
'/>"/>

SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Upsher-Smith Announces New Formulation of PreNexa(R) Prenatal Vitamins
2. New Data: Cholesterol Management Analysis of Upsher-Smiths Slo-Niacin(R) Tablets in Combination with Lipitor(R)
3. Upsher-Smith Announces Milestone in Development of CNS Strategy
4. Upsher-Smith Introduces New Formulation of PreNexa® Prenatal Vitamins
5. Upsher-Smith Laboratories Announces Initiation of Phase III Clinical Trial of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
6. Upsher-Smith Laboratories Adds ITI-111 (Nasal Midazolam) to CNS Development Pipeline
7. Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem® 10 mcg
8. Upsher-Smith Laboratories Announces Initiation of Open-Label Extension Study of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
9. Upsher-Smith Introduces Nexa™ Select With More Plant-Based DHA Than Any Other Once-Daily Single Gel Capsule Rx Prenatal Vitamin
10. Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall
11. Upsher-Smith Receives Prestigious DIANA Award for Third Year in a Row
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... YORK , May 24, 2013 In accordance ... Rules and Rule 14e-1 of the United States Exchange Act, ... its original offer for Elan Corporation (NYSE: ELN). ... Limited ("Royalty Pharma") made an offer for the entire of ... Corporation, plc ("Elan") (the "Original Offer").  On ...
(Date:5/23/2013)... , May 23, 2013  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... been named the 2013 Life Science Firm of the Year ... (TCM).  Vanda was honored at the TCM,s 25 th ... , Maryland.  The Tech Awards Celebration recognizes the leaders and ... Maryland and the surrounding regions. ...
(Date:5/23/2013)... , May 23, 2013 Nephros, Inc. ... stage medical device company that develops and sells high ... of its rights offering.  In addition, the concurrent temporary ... warrants expired on May 17, 2013. Nephros ... million from the rights offering.   A portion of the ...
Breaking Medicine Technology:Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... 2012 Futuremed Healthcare Products Corporation ("Futuremed") (TSX: FMD) ... wholly-owned subsidiary of Cardinal Health, Inc. (NYSE: ... a ,no action letter, this morning regarding Cardinal Health ... shares ("Common Shares") of Futuremed for CAD $8.15 per ...
... Mich., Feb. 16, 2012  Ministry Health Care, a ... Minnesota, has become one of only 17 hospital ... electronic medical record systems.  This milestone was accomplished ... a new Meaningful Use Quality Manager product to ...
Cached Medicine Technology:Cardinal Health Canada Inc. Receives Competition Bureau Clearance for Acquisition of Futuremed 2Cardinal Health Canada Inc. Receives Competition Bureau Clearance for Acquisition of Futuremed 3Cardinal Health Canada Inc. Receives Competition Bureau Clearance for Acquisition of Futuremed 4Thomson Reuters Teams With Ministry Health Care to Develop Meaningful Use Quality Manager 2Thomson Reuters Teams With Ministry Health Care to Develop Meaningful Use Quality Manager 3
(Date:5/24/2013)... Bridal Buy , a leading wedding dress online ... dresses are available in its wedding dresses 2013 ... fine fabrics, elegant beading, and exquisite embroidery. , ... eye for detailed designs. However, our lace spring wedding ... patterns and the hands of dressmakers,” said, Donnie Terry, ...
(Date:5/24/2013)... 2013 Psoriasis treatment cream has been ... This new FDA registered company is now offering its ... appearance of Psoriasis infected skin. , Dermasis has launched ... online. This soothing cream is designed to offer immediate ... and appearance of red skin often caused by psoriasis ...
(Date:5/23/2013)... blood glucose is associated with poor outcomes in hospitalized ... control hyperglycemia is a common practice in hospitals. But ... and even shows harms associated with the use of ... Clinical Guidelines Committee in a new evidence-based paper published ... Quality . , "Clinicians caring for hospitalized patients must ...
(Date:5/23/2013)... 24, 2013 On March 14, 2012, Kim ... will hear in her lifetime: she had breast cancer. Her ... After a Breast Cancer Diagnosis ” (published by AuthorHouse), takes ... Rideout drew from her daily journals to give readers a ... chemotherapy and radiation treatments to deal with stage two breast ...
(Date:5/23/2013)... May 23, 2013 If you are ... irritable bowel syndrome (IBS), the food spread this Memorial ... fun. , “While hot dogs and ice cream have ... warm weather months, IBS sufferers often feel the painful ... MD, a gastroenterologist with Lourdes Medical Associates. , IBS ...
Breaking Medicine News(10 mins):Health News:Dermasis Psoriasis Treatment Cream for Men and Women Released Online at HealthCareSupplementz.com 2Health News:ACP issues recommendations for management of high blood glucose in hospitalized patients 2Health News:Kimberley Rideout Shares Her Triumphant Cancer Survival Story 2Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 2Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 3
... VSCP ), a leading provider of quantitative ... the company,s chief executive,officer, will be presenting a corporate ... Conference at the Waldorf Astoria in New York City. ... at 3:45pm EST. , A ...
... finds all breaks, not just hip fractures, tied to increased ... fracture that occurs in people over age 60 needs to ... the Australian researchers found the risk of dying goes up ... for at least 10 years after a hip fracture. , ...
... former Senator Tom Daschle withdrew his name for consideration ... Human Services Department (HHS). From the beginning Senator ... for President Obama for a government takeover of our ... record while in the Senate, Family Research Council has ...
... Nearly three out of four Americans (71 ... cost of addiction treatment - yet most consumers ... would pay for substance abuse treatment, according to ... Hazelden, the national nonprofit organization that helps people ...
... until third year, study finds , , TUESDAY, Feb. ... period" for hormone replacement therapy has been identified ... that using estrogen-plus-progesterone therapy increases the risk for ... than taking estrogen alone. , The finding follows ...
... One-fifth of women who should receive radiation after a ... to a new study from researchers at the University ... at 396 women who were treated with a mastectomy ... of women who fell clearly within guidelines recommending radiation ...
Cached Medicine News:Health News:VirtualScopics to Present at 11th Annual BIO CEO & Investor Conference 2Health News:Fractures in Older Adults Up Death Risk 2Health News:Three-Quarters of Americans Believe Health Insurance Should Pay for Addiction Treatment, Yet Most Don't Know If Their Health Plan Covers Substance-Abuse Care, Says New Hazelden Survey 2Health News:Three-Quarters of Americans Believe Health Insurance Should Pay for Addiction Treatment, Yet Most Don't Know If Their Health Plan Covers Substance-Abuse Care, Says New Hazelden Survey 3Health News:Three-Quarters of Americans Believe Health Insurance Should Pay for Addiction Treatment, Yet Most Don't Know If Their Health Plan Covers Substance-Abuse Care, Says New Hazelden Survey 4Health News:2 Years of Hormone Use May Be 'Safe' 2Health News:19 percent of breast cancer patients don’t receive recommended radiation after mastectomy 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: